ReviewCancer drug resistance (Alhambra, Calif.)2024

Mechanisms of action and resistance to anti-HER2 antibody-drug conjugates in breast cancer.

Khalil Saleh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.